Interestingly, we observed a replicative advantage of VSV∆51-amiR-4 in ARID1A-expressing pancreatic cancer patient-derived samples using our unique biobank of pancreatic cancer patient-derived xenografts (Fig. 2i, j). The gene discussed is ARID1A; the disease is pancreatic neoplasm.